LUPRON DEPOT-PED KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lupron Depot-ped Kit, and what generic alternatives are available?
Lupron Depot-ped Kit is a drug marketed by Abbvie Endocrine Inc and is included in one NDA. There are two patents protecting this drug.
This drug has thirty-five patent family members in twenty-eight countries.
The generic ingredient in LUPRON DEPOT-PED KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lupron Depot-ped Kit
A generic version of LUPRON DEPOT-PED KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUPRON DEPOT-PED KIT?
- What are the global sales for LUPRON DEPOT-PED KIT?
- What is Average Wholesale Price for LUPRON DEPOT-PED KIT?
Summary for LUPRON DEPOT-PED KIT
International Patents: | 35 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 133 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LUPRON DEPOT-PED KIT at DailyMed |
![LUPRON DEPOT-PED KIT drug patent expirations Drug patent expirations by year for LUPRON DEPOT-PED KIT](/p/graph/s/t/LUPRON_DEPOT-PED_KIT-patent-expirations.png)
Recent Clinical Trials for LUPRON DEPOT-PED KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Panbela Therapeutics | Phase 2 |
Prostate Cancer Foundation | Phase 2 |
Emory University | Phase 4 |
US Patents and Regulatory Information for LUPRON DEPOT-PED KIT
LUPRON DEPOT-PED KIT is protected by two US patents and one FDA Regulatory Exclusivity.
Patents protecting LUPRON DEPOT-PED KIT
Sustained-release composition and method for producing the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Sustained-release composition and method for producing the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PEDIATRIC PATIENTS WITH CENTRAL PRECOCIOUS PUBERTY
FDA Regulatory Exclusivity protecting LUPRON DEPOT-PED KIT
NEW STRENGTH
Exclusivity Expiration: ⤷ Sign Up
Expired US Patents for LUPRON DEPOT-PED KIT
International Patents for LUPRON DEPOT-PED KIT
See the table below for patents covering LUPRON DEPOT-PED KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | T43488 | ⤷ Sign Up | |
Taiwan | I481424 | ⤷ Sign Up | |
Austria | 42197 | ⤷ Sign Up | |
Finland | 910674 | ⤷ Sign Up | |
Eurasian Patent Organization | 016176 | КОМПОЗИЦИЯ С ЗАМЕДЛЕННЫМ ВЫСВОБОЖДЕНИЕМ И СПОСОБ ЕЁ ПОЛУЧЕНИЯ (SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME) | ⤷ Sign Up |
Hungary | 211586 | ⤷ Sign Up | |
Peru | 20081842 | COMPOSICION DE LIBERACION SOSTENIDA Y METODOS PARA PRODUCIRLAS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |